Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Maternal Health topic
No spam. Unsubscribe anytime.
House approves Medicaid coverage for home blood-pressure monitors to address maternal health
Summary
House Bill 1234, which would provide Medicaid and CHIP enrollees with medically necessary home blood-pressure monitors for preeclampsia risk, passed the House by recorded vote on July 1, 2025.
Harrisburg — The Pennsylvania House passed House Bill 1234 on July 1, 2025, a measure to provide medically necessary home blood-pressure monitors to Medicaid and CHIP enrollees at risk of preeclampsia and hypertensive disorders of pregnancy.
Rep. Mays (Allegheny County), maker of the bill, framed the measure as a bipartisan effort to reduce preventable maternal deaths and complications. On the floor she said preeclampsia affects 5–8% of births, contributes to premature births, and that 42% of related medical treatment in the U.S. is paid by Medicaid. Mays cited disparities in maternal mortality — noting that Black mothers in Pennsylvania are roughly twice as likely to die in the perinatal period as white mothers — and said the bill is part of a broader omnibus to address maternal health.
The clerk recorded final passage as ayes 147, nays 55. Sponsors urged the Department of Human Services to implement clinical-accuracy standards for the monitors and to ensure enrollment procedures reach eligible Medicaid and CHIP beneficiaries.
Why it matters: Hypertensive disorders in pregnancy, including preeclampsia, are leading contributors to preventable maternal morbidity and mortality. The bill directs Medicaid/CHIP coverage for tools clinicians use to monitor blood pressure remotely, which advocates say can improve detection and timely treatment.
Votes and next steps: Final passage was recorded, ayes 147, nays 55. If the bill becomes law, DHS would adopt eligibility and clinical-accuracy guidance for covered home monitors.
